Cancer panel to speak at Vail Symposium
If you go …
What: To Cure Cancer: How Science and Medicine are Battling the World’s Most Deadly Disease presented by University of Michigan Comprehensive Cancer Center doctors.
Where: Battle Mountain High School, Edwards.
When: July 30, session 1 is 10 a.m. to noon and session 2 is from 1 p.m. to 3 p.m.
Cost: $65, includes both sessions and lunch. Each session is available separately for $35.
More information: Visit VailSymposium.org or call 970-476-0954 to register.
VAIL — In partnership with the University of Michigan Comprehensive Cancer Center, an internationally recognized leader in researching and developing future cancer treatments, the Vail Symposium will present two sessions to explore what is being done to identify, treat and beat cancer.
The program takes place July 30 over two sessions at Battle Mountain High School beginning at 10 a.m.
“This program takes the Symposium’s rich history with presenting breakthroughs on the medical front to a completely new level,” said Dale Mosier, the Symposium’s chairman of the board of directors. “I think the audience will leave with a broad understanding, to the point of excitement, about what is going on at the forefront of cancer prevention and treatment.”
The event will feature six panelists: Dr. Theodore Lawrence, director of University of Michigan Comprehensive Cancer Center; Dr. Gary Hammer, director of the Endocrine Oncology Program; Dr. Michael Sabel, chief of the Division of Surgical Oncology; Dr. Judy Sebolt-Leopold, principal investigator in the Translational Oncology Program; Dr. Thomas Wang, physician scientist; and Dr. Patricia Hardenbergh, medical director of radiation oncology at the Shaw Regional Cancer Center in Edwards.
Cancer becomes deadly when it spreads throughout the body. That’s why University of Michigan Comprehensive Cancer Center researchers are focusing on early detection and developing promising techniques to identify precancerous tissue and better tests for population-based screening. By detecting cancer early, they can treat it more effectively and improve the quality and quantity of life.
It is also known that certain genes are associated with a higher risk of cancer. These scientists are at the forefront of identifying genes and other markers that increase a person’s likelihood of developing cancer. They can then evaluate and counsel individuals, helping them understand and manage their risk to prevent tumors.
University of Michigan Comprehensive Cancer Center doctors are poised to revolutionize how cancer is treated. Armed with new insights into the disordered wiring circuits of cancer cells, major technological advancements and a multidisciplinary collaborative approach, doctors are on the brink of discoveries that promise to usher in an entirely new era.
Gone are the days of looking for a “one-size-fits-all” treatment for cancer in general or even particular cancer types. The speakers are conducting the world’s most advanced genomic analysis in patients, leveraging cutting edge DNA and RNA sequencing technologies to identify precise treatments to match their cancer “fingerprint.”
A social hour with lunch and interaction with the doctors will take place between sessions.
“We are very excited to host the panelists at the end of July,” Mosier said. “With that, we are equally happy to host an audience eager to learn about the developments in a battle against a disease that has impacted so many.”